CureGenetics, a biotech company founded in SIP in 2016, recently inaugurated its Genetic Engineering & Cell Therapies R&D Center in the area.

CureGenetics has been engaged in developing life-saving medicines and technologies including best-in-class gene editing technologies for use in cell therapies against tumors and complicated genetic diseases. The new R&D center, consisting of a production workshop and an experimental platform with a total floor area of about 3,000 square meters, is expected to help the company accelerate the steps to bring its inventions into clinical trials.